"Almac Diagnostics is poised
to change the way medicines
are developed, regulated
and prescribed"
Paul Harkin - President and Managing Director

The Experts in Personalised Medicine

Almac Diagnostics a personalised medicine company focused on the discovery, development and commercialisation of diagnostic tests including companion diagnostics. Our approach to personalised medicine is poised to change the way that medicines are developed, regulated and prescribed. We partner with biopharma companies to provide solutions ranging from pre-clinical biomarker discovery to companion diagnostic development including regulatory submissions and commercialisation. We also facilitate biomarker clinical trial management and clinical test delivery from our CLIA lab. The tests developed at Almac Diagnostics have a wide range of applications including patient selection, and are utilized in phase I to phase III registrational clinical trials.

An emphasis on scientific and technological excellence combined with a committed and passionate multi-functional team, puts Almac Diagnostics in a leadership position to take companion and other diagnostic tests all the way through development and to commercialisation.

Read more

Head of Laboratory Operations Dr. Leeona Galligan presents details on the development and implementation of a clinical NGS assay for TP53 which is being used routinely for clinical trial stratification.
Video: Almac Diagnostics
Paul Harkin, Michael Sloan & Richard Kennedy explain how Almac Diagnostics are developing novel Diagnostic tests to better manage patient care.
Contact us or give us feedback get in touch